Abbott Laboratories (ABT)

Stay informed with Abbott Laboratories (ABT) share price and trends to guide your investment strategy. Stay updated with FP Markets Indonesia.

Pricing is indicative. Past performance is not a reliable indicator of future results. Log in to see latest markets data.

Abbott Laboratories (ABT) Profile

Abbott Laboratories (ABT.xnys) is a multinational medical devices and health care company headquartered in Abbott Park, Illinois, America. Abbott sells medical devices, diagnostics, branded generic medicines and nutritional products, and its well-known products are Pedialyte, Similac, Ensure, Glucerna, ZonePerfect, FreeStyle Libre, i-STAT and MitraClip. The company operates in over 160 countries and employs 109,000 people. Due to the COVID-19 pandemic, Abbott delivered more than 400M tests at the beginning and 300M in the fourth quarter of 2020. Abbott has been an important key for detecting the complex virus and getting patients treatment but also brought faster testing with a low-cost rapid antigen test that helped schools and workplaces reopen earlier. The Abbott Laboratories stock (ABT.xnys) is listed on the New York Stock Exchange (NYSE), had a market capitalisation of $240.08B (USD) as of January 2022 and $34.61B in 2020 yearly revenue. Abbott, after the acquisition of WALK Vascular in September 2021, announced that the Food and Drug Administration (FDA) had approved new expanded magnetic resonance imaging (MRI) compatibility for its Proclaim XR Spinal Cord Stimulation (SCS) System with Octrode leads.

Start Trading Abbott Laboratories (ABT) with a Market Leader Today

Abbott Laboratories (ABT) Trading FAQ

Shares represent units of ownership within a company. Shares are also known as stocks or equities. Dividend payments are common with some companies, a method of sharing company profits with shareholders. In addition to traditional share dealing, however, traders can access derivatives: trading instruments derived from the movement of an underlying share price.

Individual stock CFDs (contract for differences) fall under the umbrella of derivative products, an effective low-cost trading vehicle. While CFDs do not grant shareholder privileges, active CFD positions may receive a dividend if executed before the ex-dividend date.

Start Trading
in minutes

Get instant Updates in Telegram